IRON Overview

Company Profile

Related stocks

PVLA • United States

Palvella Therapeutics, Inc.

138.77 USD

2B USD 1Y +75.5%

BEAM • United States

Beam Therapeutics Inc.

25.7 USD

2.65B USD 1Y -8.9%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

SEPN • United States

Septerna, Inc.

38.37 USD

1.79B USD 1Y +64.1%

PBLS • United States

Parabilis Medicines, Inc.

27.48 USD

3.39B USD

NRIX • United States

Nurix Therapeutics, Inc.

22.35 USD

2.32B USD 1Y +122.5%

MAZE • United States

Maze Therapeutics, Inc.

27.11 USD

1.51B USD 1Y -9.5%

KLRA • United States

Kailera Therapeutics, Inc.

11.61 USD

1.51B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

67.9% p.a.

Max Drawdown (5Y)

-84.7%

Sharpe Ratio (5Y)

-0.20

Beta Factor

2.11

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

High market risk: Beta of 2.11 indicates above-average volatility compared to the broader market.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (67.9% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -84.7% in the extended horizon.